2026 GINA Severe Asthma Guide
Clinicians treating one of the world’s most common chronic lung diseases need a concise, current reference for difficult-to-treat asthma.
Summary
The Global Initiative for Asthma’s 2026 Severe Asthma Guide, formally titled “Difficult-to-Treat & Severe Asthma in Adolescent and Adult Patients: Diagnosis and Management,” is a short reference for health professionals summarizing current scientific literature on severe and difficult-to-treat asthma, one of the most common chronic lung diseases worldwide. Reviewed by an international panel on the GINA Science Committee, it is based on the 2026 GINA Strategy Report and forms the basis for other GINA clinical materials and programs.
Why it’s important
The page itself provides no narrative on importance or impact beyond describing the guide as a clinical reference document. It notes the guide addresses “one of the most common chronic lung diseases worldwide.” GINA materials are copyrighted; the guide may not be redistributed or reproduced without GINA’s authorization.
Real-world impact
Not described on this page beyond “a review of recent scientific literature by an international panel of experts on the GINA Science Committee.” No design, research, or authorship credits are listed.
To learn more: https://ginasthma.org/2026-gina-severe-asthma-guide/
Adapted from: Global Initiative for Asthma (GINA). “Difficult-to-Treat & Severe Asthma in Adolescent and Adult Patients: Diagnosis and Management,” 2026 update, based on the 2026 GINA Strategy Report (May 5, 2026). https://ginasthma.org/2026-gina-severe-asthma-guide/. No individual byline; Tomoko Ichikawa’s or Maykawa Studios’ involvement in this document could not be confirmed on the page or site.
